SCHEMBL877126

SCHEMBL877126

C=CCOC(=O)c1cccc(N)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
TSHR P16473 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CYP3A4 P08684 1/20 0.53
ADRB2 P07550 3/20 0.49
ADRB1 P08588 3/20 0.49
ADRB3 P13945 3/20 0.49
CHRNB2 P17787 1/20 0.47
CHRNA4 P43681 1/20 0.47
PBRM1 Q86U86 1/20 0.46
SNCA P37840 1/20 0.46
RHOA P61586 1/20 0.43
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41
MITF O75030 1/20 0.41
POLB P06746 1/20 0.41
FGFR1 P11362 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7617858 0.98 ALDH1A1 (0.53) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL157805 0.88 CYP3A4 (0.61) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL16372021 0.88 CYP3A4 (0.61) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
Benzene SCHEMBL29140663 0.86 CYP3A4 (0.59) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL9576387 0.85 CYP3A4 (0.58) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL27389265 0.84 CYP3A4 (0.53) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL6284521 0.83 CYP3A4 (0.56) ALDH1A1TSHRHSD17B10CYP3A4ADRB2
SCHEMBL5095083 0.83 ALDH1A1 (0.51) ALDH1A1TSHRHSD17B10CYP3A4SNCA
SCHEMBL5557935 0.83 ALDH1A1 (0.51) ALDH1A1TSHRHSD17B10CYP3A4SNCA
SCHEMBL2787842 0.82 CYP3A4 (0.54) ALDH1A1TSHRHSD17B10CYP3A4ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120600825-B All-solid-state composite dry-method conductive agent and preparation method thereof 江苏华永烯科技有限公司 2025-09-30 CN disclosed
CN-120600825-A All-solid-state composite dry-method conductive agent and preparation method thereof 江苏华永烯科技有限公司 2025-09-05 CN disclosed
CN-118630308-A Polymer solid electrolyte, preparation method thereof and battery 重庆太蓝新能源有限公司 2024-09-10 CN disclosed
EP-2585459-B1 Alkaloid aminoester derivatives and medicinal compositions thereof CHIESI FARMA SPA (IT) 2015-01-07 EP disclosed
US-8492548-B2 Alkaloid aminoester derivatives and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-23 US disclosed
US-8492548-B2 Alkaloid aminoester derivatives and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-23 US disclosed
US-8492548-B2 Alkaloid aminoester derivatives and medicinal compositions thereof CHIESI FARMACEUTICI S.P.A. (IT) 2013-07-23 US disclosed
EP-2585459-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF Chiesi Farmaceutici S.p.A. (IT) 2013-05-01 EP disclosed
US-20120225309-A1 Method of Preparing a Polyetherimide Coating on a Metallic Substrate TATA STEEL NEDERLAND TECHNOLOGY BV (NL) 2012-09-06 US disclosed
EP-2480592-A1 A METHOD OF PREPARING A POLYETHERIMIDE COATING ON A METALLIC SUBSTRATE Tata Steel Nederland Technology B.V. (NL) 2012-08-01 EP disclosed
US-5652233-A CARBAPENICILLINS ZENECA LIMITED (GB) 1997-07-29 US disclosed
EP-0763011-A1 PROCESS FOR THE PREPARATION OF UNSATURATED AMINO COMPOUNDS Novartis AG (CH) 1997-03-19 EP disclosed
US-5538962-A PENICILLINS ZENECA LIMITED (GB) 1996-07-23 US disclosed
US-5478820-A Carbapenem deivatives; bactericides ZENECA LTD. (GB) 1995-12-26 US disclosed
WO-1995032941-A1 PROCESS FOR THE PREPARATION OF UNSATURATED AMINO COMPOUNDS CIBA-GEIGY AG (CH) 1995-12-07 WO disclosed
WO-1995032952-A1 PROCESS FOR THE PREPARATION OF 3-ARYLURACILS CIBA-GEIGY AG (CH) 1995-12-07 WO disclosed
EP-0592167-A1 Antibiotic pyrrolidinylthiopenem derivatives ZENECA LIMITED (GB) 1994-04-13 EP disclosed
EP-0579826-A1 CARBAPENEMS CONTAINING A CARBOXY SUBSTITUTED PHENYL GROUP, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND USE AS ANTIBIOTICS ZENECA LIMITED (GB) 1994-01-26 EP disclosed
WO-1993015078-A1 CARBAPENEMS CONTAINING A CARBOXY SUBSTITUTED PHENYL GROUP, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND USE AS ANTIBIOTICS ZENECA LIMITED (GB) 1993-08-05 WO disclosed
US-4051177-A PROCESS FOR THE PREPARATION OF UNSATURATED AMINO COMPOUNDS BAYER AKTIENGESELLSCHAFT (DT) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120225309-A1 Method of Preparing a Polyetherimide Coating on a Metallic Substrate PUF60, AOC1, PARG ALDH1A1 2568/4885TSHR 3891/4885HSD17B10 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.